New drug trial targets painful skin condition that resists antibiotics

NCT ID NCT06956235

Ongoing Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing an investigational drug called tulisokibart for people with moderate to severe hidradenitis suppurativa (HS), a chronic, painful skin condition. The main goal is to see if the drug can reduce the number of painful abscesses and nodules by at least 50% after 16 weeks of treatment, compared to a placebo. Researchers will also measure its safety and how it affects participants' quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

AOU Ospedali Riuniti di Ancona ( Site 1805)

Ancona, The Marches, 60126, Italy
Amphia Ziekenhuis, locatie Breda Molengracht ( Site 0902)

Breda, North Brabant, 4818 CK, Netherlands
Arlington Center for Dermatology ( Site 0045)

Arlington, Texas, 76011, United States
Beth Israel Deaconess Medical Center ( Site 0044)

Boston, Massachusetts, 02215, United States
Brunswick Dermatology Center ( Site 0101)

Frederiction, New Brunswick, E3B 1G9, Canada
CHU de Bordeaux Hop St ANDRE ( Site 0603)

Bordeaux, Gironde, 33000, France
CIPREC ( Site 0202)

CABA, C1061AAT, Argentina
Cahaba Dermatology & Skin Health Center ( Site 0012)

Birmingham, Alabama, 35244, United States
Centro Internacional de Estudios Clinicos (CIEC) ( Site 0302)

Santiago, Region M. de Santiago, 8420383, Chile
Centro Skin Med Limitada ( Site 0305)

Santiago, Region M. de Santiago, 7580206, Chile
Charite - Universtitatsmedizin Berlin CCM ( Site 0708)

Berlin, 10117, Germany
Clinica Dermacross ( Site 0301)

Santiago, Region M. de Santiago, 7640881, Chile
DJL Clinical Research, PLLC ( Site 0021)

Charlotte, North Carolina, 28211, United States
Dawes Fretzin Clinical Research Group, LLC ( Site 0025)

Indianapolis, Indiana, 46250, United States
Derma Internacional SA ( Site 0206)

CABA, C1426EGR, Argentina
Dermatology Hospital of Southern Medical University ( Site 1504)

Guangzhou, Guangdong, 516006, China
Erasmus Medisch Centrum ( Site 0901)

Rotterdam, South Holland, 3015 GD, Netherlands
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico ( Site 1806)

Milan, 20122, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1801)

Roma, 00168, Italy
Frankfurt Universitaetsklinikum EC ( Site 0706)

Frankfurt am Main, Hesse, 60590, Germany
Fremantle Dermatology ( Site 1402)

Fremantle, Western Australia, 6160, Australia
Fukuoka University Hospital ( Site 1604)

Fukuoka, 814-0180, Japan
Fundación Valle del Lili ( Site 0403)

Cali, Valle del Cauca Department, 760032, Colombia
HIA Sainte Anne ( Site 0606)

Toulon, Var, 83800 Cede, France
Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 0602)

Paris, 75679, France
Hospital Italiano de Buenos Aires ( Site 0205)

CABA, C1199ABB, Argentina
Hospital Universitari Vall d'Hebron ( Site 1102)

Barcelona, 08035, Spain
Hospital Universitari de Bellvitge ( Site 1101)

Barcelona, 08907, Spain
Hospital Universitario Virgen Nieves ( Site 1104)

Granada, 18012, Spain
Hospital de Manises ( Site 1103)

Manises, Valencia, 46940, Spain
Huashan Hospital of Fudan University ( Site 1506)

Shanghai, Shanghai Municipality, 200040, China
Hôpital Edouard Herriot ( Site 0601)

Lyon, Auvergne-Rhône-Alpes, 69003, France
Integrative Skin Science and Research ( Site 0015)

Sacramento, California, 95815, United States
Liverpool Hospital ( Site 1403)

Liverpool, New South Wales, 1871, Australia
Lynderm Research Inc. ( Site 0104)

Markham, Ontario, L3P 1X3, Canada
Medical Corporation Kojinkai Sapporo Skin Clinic ( Site 1606)

Sapporo, Hokkaido, 060-0063, Japan
Medical Dermatology Specialists ( Site 0027)

Phoenix, Arizona, 85006, United States
Mount Sinai Doctors - East 85th Street ( Site 0050)

New York, New York, 10028, United States
Nagoya City University Hospital ( Site 1603)

Nagoya, Aichi-ken, 467-8602, Japan
National Skin Centre ( Site 0801)

Singapore, Central Singapore, 308205, Singapore
National Universtity Hospital IMU ( Site 0802)

Singapore, Central Singapore, 117599, Singapore
Nihon University Itabashi Hospital ( Site 1602)

tabashi City, Tokyo, 173-8610, Japan
Northridge Clinical Trials ( Site 0004)

Northridge, California, 91325, United States
Northwest Arkansas Clinical Trials Center, PLLC ( Site 0049)

Rogers, Arkansas, 72758, United States
Olympian Clinical Research ( Site 0010)

Tampa, Florida, 33615, United States
PEOPLE'S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION ( Site 1509)

Ürümqi, Xinjiang, 830001, China
Palmetto Clinical Trial Services, LLC ( Site 0023)

Anderson, South Carolina, 29621, United States
Progressive Clinical Research ( Site 0020)

San Antonio, Texas, 78213, United States
Psoriahue ( Site 0203)

CABA, C1425DKG, Argentina
Reveal Research Institute ( Site 0018)

Frisco, Texas, 75033, United States
Revival Research Institute, LLC ( Site 0005)

Troy, Michigan, 48084, United States
Royal London Hospital ( Site 1301)

London, England, E1 1BB, United Kingdom
Ruijin Hospital Shanghai Jiaotong University School of Medicine ( Site 1515)

Shanghai, Shanghai Municipality, 200025, China
Russells Hall Hospital ( Site 1303)

Dudley, England, DY1 2HQ, United Kingdom
SKiN Centre for Dermatology ( Site 0103)

Peterborough, Ontario, K9J 5K2, Canada
Servicios de Salud IPS Suramericana S.A.S. - IPS Sura San Diego ( Site 0404)

Medellín, Antioquia, 050021, Colombia
Skin Care Physicians of Georgia ( Site 0033)

Macon, Georgia, 31217, United States
Texas Dermatology Research Center ( Site 0019)

Dallas, Texas, 75246, United States
The Alfred Hospital ( Site 1401)

Melbourne, Victoria, 3004, Australia
The First Hospital of Jilin University ( Site 1502)

Changchun, Jilin, 130021, China
The Second Xiangya Hospital of Central South University ( Site 1505)

Changsha, Hunan, 410011, China
The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 1501)

Hangzhou, Zhejiang, 310003, China
University Hospital,Kyoto Prefectural University of Medicine ( Site 1605)

Kyoto, 602-8566, Japan
University Hospitals Cleveland Medical Center ( Site 0046)

Cleveland, Ohio, 44106, United States
University of the Ryukyus Hospital ( Site 1601)

Ginowan, Okinawa, 901-2725, Japan
Wiseman Dermatology Research Inc. ( Site 0107)

Winnipeg, Manitoba, R3M 3Z4, Canada
Wright State Physicians Health Center ( Site 0041)

Fairborn, Ohio, 45324, United States
York Dermatology Clinic & Research Centre ( Site 0106)

Richmond Hill, Ontario, L4B 1L1, Canada

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA